ArticleJournal of labelled compounds & radiopharmaceuticals2014

Preparation of clinical-grade (89) Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy.

Ling Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.